The Peptide Revolution: Past, Present, and Future (Hardcover) (ISBN-13: 9781631441288)

Brigham Buhler is a healthcare entrepreneur, founder of Ways2Well, and owner of ReviveRx Pharmacy. A former pharmaceutical and medical device insider, Buhler has spent more than two decades working across the systems that shape American healthcare--from pharmacy access and clinical diagnostics to preventative care, hormone optimization, and regenerative medicine. His work focuses on exposing the incentives that keep patients sick while building practical alternatives rooted in transparency, clinician guidance, and proactive health optimization. Through Ways2Well and ReviveRx, Buhler is helping advance a model of care that prioritizes patient access, better data, legitimate pharmacy oversight, and healthspan over disease management.

Lee H. Rosebush, Pharm.D, JD, MBA, MS, is chairman of the Outsourcing Facilities Association (OFA), which represents FDA-registered 503B outsourcing facilities nationwide. A pharmacist and attorney with experience spanning hospital, retail, and regulatory settings, he advises on compounding policy, patient access, and the legal and operational issues shaping the industry. He has been active in state and national compounding policy efforts, including support for Colorado's HB26-1262, Patient Access to Compounded Medical Items. Through legislative testimony and public advocacy, Rosebush has helped clarify issues affecting access to compounded medications and the alignment of state requirements with federal 503B standards. He also speaks and writes frequently on FDA compounding regulation, the Drug Quality and Security Act (DQSA), drug shortages, and broader pharmacy policy issues. Drawing on prior regulatory experience in the FDA's Office of Orphan Products Development, he provides strategic counsel on compliance, advocacy, and emerging industry challenges. His work bridges legal, regulatory, and policy considerations for stakeholders navigating a complex and evolving compounding landscape.